Claudio A. Benadiva, M.D., HCLDProfessor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, UConn Health
Medical Director, Center for Advanced Reproductive Service
Dr. Claudio Benadiva is the Medical Director of the Center for Advanced Reproductive Services, affiliated with the University of Connecticut. In addition to being a Professor of Obstetrics and Gynecology, he is a Fellow of the American Congress of Obstetricians and Gynecologists and board-certified in obstetrics and gynecology and reproductive endocrinology and infertility.
Dr. Benadiva is among the very few physicians who are certified by the American Board of Bioanalysis as a High Complexity Laboratory Director, making him uniquely suited to integrate both clinical and laboratory protocols in an IVF program. He has been awarded "Best Doctor in America" every year since 2001.
Dr. Benadiva graduated from the University of Buenos Aires School of Medicine in 1981 and completed his residency in OB/GYN at the UConn School of Medicine. He completed a Research Fellowship in Reproductive Biology and Endocrinology at the University of Pennsylvania School of Medicine in 1988, and a Clinical Fellowship in Reproductive Endocrinology at The New York Hospital-Cornell Medical Center in 1995.
Dr. Benadiva has done extensive research in reproductive biology and endocrinology since 1986. His work has resulted in over 80 peer-reviewed articles, 160 abstract presentations and invited book chapters.
He continues to lecture nationally and internationally, with a special interest in ovulation induction for in-vitro fertilization (IVF), preimplantation genetic testing (PGT), and methods for prevention of ovarian hyperstimulation syndrome (OHSS).
|B.S.||University of Buenos Aires||Premed|
|M.D.||University of Buenos Aires||Medicine|
|Residency||Mariano Castex Hospital||Obstetrics and Gynecology|
|Fellowship||University of Pennsylvania Medical Center||Research Fellow, Reproductive Biology and Endocrinology|
|Residency||University of Connecticut School of Medicine||Obstetrics and Gynecology|
|Fellowship||Center for Reproductive Medicine, New York Hospital-Cornell Medical Center||Reproductive Endocrinology|
|Name of Award/Honor||Awarding Organization|
|ASRM 2012 Star Award||ASRM|
|Best Doctors in America-2012|
|Best Doctors in America-2011|
|Top Obstetrician and Gynecologist-2010||Guide to America’s Top Obstetricians and Gynecologists|
|Best Doctors in America-2010|
|Top Obstetrician and Gynecologist-2009||Guide to America’s Top Obstetricians and Gynecologists|
|Best Doctors in America-2009|
|Greater Hartford’s Top Docs-2009||Hartford Magazine|
|Top Obstetrician and Gynecologist-2008||Guide to America’s Top Obstetricians and Gynecologists|
|Greater Hartford’s Top Docs-2008||Hartford Magazine|
|Top Obstetrician and Gynecologist-2007||Guide to America’s Top Obstetricians and Gynecologists|
|Greater Hartford’s Top Docs-2007||Hartford Magazine|
|Best Doctors in America-2007|
|Greater Hartford’s Top Docs-2006||Hartford Magazine|
|Greater Hartford’s Top Docs-2005||Hartford Magazine|
|Best Doctors in America-2005|
|Family Building Award||American Fertility Association|
|Greater Hartford’s Top Docs-2004||Hartford Magazine|
|Top Obstetrician and Gynecologist-2004||Guide to America’s Top Obstetricians and Gynecologists|
|Best Doctors in America-2003|
|Top Docs for Women||Connecticut Magazine|
|Best Doctors in America-2001|
|Society for Assisted Reproductive Technology (SART) Prize Paper Award||American Society for Reproductive Medicine|
|Annual Award for Excellence in Endoscopic Gynecology||American Association of Gynecologic Laparoscopists|
|Resident Achievement Award||Society of Laparoendoscopic Surgeons|
|Dr. Spero Neckles Outstanding Resident Research Paper Award||University of Connecticut School of Medicine|
|Berlex Foundation Resident Education Award||Berlex Foundation|
|Degree with honors in Medicine||University of Buenos Aires School of Medicine|
|Bunge & Born Foundation Award||Argentine Society of Uterine-Cervical Pathology and Colposcopy|
|Name & Description||Category||Role||Type||Scope||Start Year||End Year|
|Greater Hartford Obstetrical & Gynecological Society||Professional/Scientific Organization||President||External||Regional||2009|
|Greater Hartford Obstetrical & Gynecological Society||Professional/Scientific Organization||Vice-President||External||Regional||2008|
|American Institute of Ultrasound in Medicine||Professional/Scientific Organization||Member||External||National||2005|
|American Association of Bioanalysts||Professional/Scientific Organization||Member||External||National||2004|
|New England Fertility Society||Professional/Scientific Organization||Member||External||Regional||2003|
|Preimplantation Genetic Diagnosis International Society||Professional/Scientific Organization||Member||External||International||2003|
|The Polycystic Ovarian Syndrome Association||Professional/Scientific Organization||Member||External||National||2001|
|American College of Obstetrics and Gynecology||Professional/Scientific Organization||Fellow||External||National||1998|
|The Society for Reproductive Endocrinology and Infertility||Professional/Scientific Organization||Active Member||External||National||1998|
|Education Committee, Department of Ob/Gyn, University of Connecticut||Education Committee||Member||UConn Health||University||1998|
|The Endocrine Society||Professional/Scientific Organization||Member||External||National||1998|
|American Medical Association||Professional/Scientific Organization||Member||External||National||1997|
|European Society of Human Reproduction and Embryology||Professional/Scientific Organization||Member||External||International||1997|
|Hartford County Medical Association||Professional/Scientific Organization||Member||External||Local||1996|
|Medical Education Committee, New Britain General Hospital||Education Committee||Member||External||Local||1996|
|Greater Hartford Obstetrical & Gynecological Society||Professional/Scientific Organization||Member||External||State||1995|
|New York Society of Reproductive Medicine||Professional/Scientific Organization||Member||External||State||1994|
|American Society for Reproductive Medicine||Professional/Scientific Organization||Active Member||External||National||1993|
|American Association of Gynecologic Laparoscopists||Professional/Scientific Organization||Member||External||National||1993|
|Society of Laparoendoscopic Surgeons||Professional/Scientific Organization||Member||External||National||1993|
The association of obesity with euploidy rates in women undergoing in vitro fertilization with preimplantation genetic testing.
Journal of assisted reproduction and genetics 2022 Oct;
Pregnancy outcomes after frozen-thawed embryo transfer using letrozole ovulation induction, natural, or programmed cycles.
Fertility and sterility 2022 Jul;
Embryologic outcomes among patients using a microfluidics chip compared to density gradient centrifugation to process sperm: a paired analysis.
Journal of assisted reproduction and genetics 2022 May;
Reduction in multiple pregnancy rate in donor oocyte-recipient gestational carrier (GC) in vitro fertilization (IVF) cycles in the USA with single-embryo transfer and preimplantation genetic testing.
Journal of assisted reproduction and genetics 2021 Mar;
Impact of trophectoderm biopsy on obstetric and perinatal outcomes following frozen-thawed embryo transfer cycles.
Human reproduction (Oxford, England) 2020 Dec;
Maternal and perinatal outcomes in programmed versus natural vitrified-warmed blastocyst transfer cycles.
Reproductive biomedicine online 2020 Aug;41(2):300-308
Pregnancy outcomes after frozen-thawed single euploid blastocyst transfer following IVF cycles using GNRH agonist or HCG trigger for final oocyte maturation.
Journal of assisted reproduction and genetics 2020 Jan;
The window is wide: flexible timing for vitrified-warmed embryo transfer in natural cycles.
Reproductive biomedicine online 2019 Aug;39(2):241-248
Independent serum markers of corpora lutea function after gonadotropin-releasing hormone agonist trigger and adjuvant low dose human chorionic gonadotropin in in vitro fertilization.
Fertility and sterility 2019 Jun;
Euploidy rates between cycles triggered with gonadotropin-releasing hormone agonist and human chorionic gonadotropin.
Fertility and sterility 2019 May;
Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
Journal of ovarian research 2019 Jan;12(1):8
Luteal phase support after gonadotropin-releasing hormone agonist triggering: does it still matter?
Fertility and sterility 2018 Apr;109763-767
Correlation of normal-range FMR1 repeat length or genotypes and reproductive parameters.
Journal of assisted reproduction and genetics 2016 May;331149-55
Occult abnormal pregnancies after first post-embryo transfer serum β-hCG levels of 1.0-5.0 mIU/mL.
Fertility and sterility 2015 Dec;105938-945.e1
A survey assessing obesity policies for assisted reproductive technology in the United States.
Fertility and sterility 2015 Dec;105703-706.e2
The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors.
Reproductive biomedicine online 2015 Jun;30(6):563-5
Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches.
Fertility and sterility 2015 Feb;103(4):879-85
Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol.
Fertility and sterility 2015 Jan;103(3):675-9
Concurrent ovarian and ipsilateral tubal ectopic pregnancies after a double embryo transfer: a case report.
Journal of assisted reproduction and genetics 2014 Sep;31(12):1643-6
Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization.
Fertility and sterility 2014 Jun;102(3):753-8
Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
Fertility and sterility 2014 May;102(2):405-9
Reproductive outcome of women 43 years and beyond undergoing ART treatment with their own oocytes in two Connecticut university programs.
Journal of assisted reproduction and genetics 2013 Jun;30(5):673-8
Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
Human reproduction (Oxford, England) 2013 Jan;28(1):152-9
Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
Fertility and sterility 2012 Jun;97(6):1316-20
Should Cochrane reviews be performed during the development of new concepts?
Human reproduction (Oxford, England) 2012 Jan;27(1):6-8
Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist.
Fertility and sterility 2011 Jul;96(1):63-8
In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation.
Fertility and sterility 2011 Jul;96(1):198-202
A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders.
Fertility and sterility 2011 Jun;95(8):2531-3
In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle.
Fertility and sterility 2011 Jun;95(8):2592-4
Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation.
Fertility and sterility 2011 Jun;95(7):2330-4
Selection of first in vitro fertilization cycle stimulation protocol for good prognosis patients: gonadotropin releasing hormone antagonist versus agonist protocols.
The Journal of reproductive medicine 2011 Jan;56(1-2):12-6
Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders.
Fertility and sterility 2011 Jan;95(1):324-6
New algorithm for OHSS prevention.
Reproductive biology and endocrinology : RB&E 2011 Jan;9147
An eye to the future.
Seminars in reproductive medicine 2010 Nov;28(6):540
Endogenous gonadotropin flare following microdose leuprolide (MDL) stimulation protocol does not correlate with in vitro fertilization (IVF) outcome.
Fertility and sterility 2010 Nov;94(6):2427-9
Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger.
Seminars in reproductive medicine 2010 Nov;28(6):506-12
Ovarian hyperstimulation syndrome: a preventable syndrome?
Seminars in reproductive medicine 2010 Nov;28(6):437-9
Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting.
Fertility and sterility 2010 Aug;94(3):1111-4
Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization.
Fertility and sterility 2010 Feb;93(2):437-41
Predictive value of embryo grading for embryos with known outcomes.
Fertility and sterility 2010 Feb;93(2):658-62
Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles.
Fertility and sterility 2010 Feb;93(2):355-9
Reproductive efficiency of women over the age of 40 and the low risk of multiple pregnancies.
Reproductive biomedicine online 2009 Jan;19 Suppl 44316
Ruptured ectopic pregnancy with contralateral adnexal torsion after spontaneous conception.
Fertility and sterility 2008 Nov;90(5):2007.e1-3
The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study.
Fertility and sterility 2008 Mar;89(3):554-61
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Fertility and sterility 2008 Jan;89(1):84-91
GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS.
Reproductive biomedicine online 2006 Nov;13(5):639-44
Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
Fertility and sterility 2006 Feb;85(2):407-11
Transferring 2 or 3 embryos in women 35 to 37 years old: influence of embryo quality and number of previous cycles on pregnancy and multiple pregnancy rates
Fertil Steril 2005 Dec;84(6):1748-51
Outcome of in vitro fertilization treatment in patients who electively inseminate a limited number of oocytes to avoid creating surplus human embryos for cryopreservation.
Fertility and sterility 2005 Nov;84(5):1406-10
A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders.
Fertility and sterility 2005 May;83(5):1568-71
Obstetrical complications in gestational carrier pregnancies.
Fertility and sterility 2005 Mar;83(3):749-54
An unusual anatomic variation of a unicornuate uterus with normal external uterine morphology.
Fertility and sterility 2004 Oct;82(4):950-3
Septate uterus with cervical duplication: a full-term delivery after resection of a vaginal septum.
Fertility and sterility 2004 Apr;81(4):1125-6
Intracytoplasmic sperm injection overcomes previous fertilization failure with conventional in vitro fertilization.
Fertility and sterility 1999 Dec;72(6):1041-4
In vitro fertilization following conservative management of stage 3 serous borderline tumor of the ovary.
Gynecologic oncology 1999 Sep;74(3):515-8
Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome.
Fertility and sterility 1997 Apr;67(4):724-7
Aneuploidy 16 in human embryos increases significantly with maternal age.
Fertility and sterility 1996 Aug;66(2):248-55
The presence of multinucleated blastomeres in human embryos is correlated with chromosomal abnormalities.
Human reproduction (Oxford, England) 1996 Jul;11(7):1492-8
In vitro fertilization versus tubal surgery: is pelvic reconstructive surgery obsolete?
Fertility and sterility 1995 Dec;64(6):1051-61
Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in vitro fertilization.
Fertility and sterility 1995 Mar;63(3):673-6
Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
Journal of assisted reproduction and genetics 1995 Jan;12(1):8-12
Management of benign ovarian cystic teratomas: laparoscopy compared with laparotomy.
The Journal of the American Association of Gynecologic Laparoscopists 1994 May;1(3):219-22
Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony.
Fertility and sterility 1994 Apr;61(4):700-4
Comparison of different regimens of a gonadotropin-releasing hormone analog during ovarian stimulation for in vitro fertilization.
Fertility and sterility 1990 Mar;53(3):479-85
Bovine serum albumin (BSA) can replace patient serum as a protein source in an in vitro fertilization (IVF) program.
Journal of in vitro fertilization and embryo transfer : IVF 1989 Jun;6(3):164-7
Cortisol levels in human follicular fluid.
Fertility and sterility 1989 Mar;51(3):538-41
Collagen matrix influences the morphologic features and steroid secretion of human granulosa cells.
American journal of obstetrics and gynecology 1988 Dec;159(6):1570-4
Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives.
Fertility and sterility 1988 Sep;50(3):516-8
Ovarian response of individuals to different doses of human menopausal gonadotropin.
Fertility and sterility 1988 Jun;49(6):997-1001
Cortisol stimulation of estradiol and progesterone secretion by human granulosa cells is independent of follicle-stimulating hormone effects.
Fertility and sterility 1988 May;49(5):813-6
Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program.
Fertility and sterility 1987 Dec;48(6):964-8
An Increased Initial FSH/LH Ratio Does Not Affect Ovarian Responses and the Outcomes of IVF
Fertil Steril 50777
Comparison of Luteal Estradiol Patch and Gonadotropin-Releasing Hormone Antagonist Suppression Protocol (LPG) before Gonadotropin Stimulation Versus Standard Microdose Lupron Protocol for Patients with a History of Poor IVF Outcomes
Fertil Steril 92226-230
GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data.
Human reproduction update 18(2):228-9; author reply 229-30
GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
Human reproduction update 17(4):510-24
Pregnancy and Multiple Pregnancy Rates in Patients with Good Prognosis Who Did or Did Not Fulfill Embryological Criteria for Extended Blastocyst Cultures and had Single or Double Embryo Transfer
Follicle stimulating hormone and anti-Müllerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort study.
PloS one 2003 Jan;7(4):e34290
Assisted Reproductive Technologies Versus Tubal Surgery
Operative Laparoscopy 278-305
Preimplantation Genetic Diagnosis and Assisted Reproduction
Infertility and Reproductive Medicine Clinics of North America 489-505
Prevention Strategies for Ovarian Hyperstimulation Syndrome
Infertility and Reproductive Medicine Clinics of North America 459-474
Manual of Ovulation Induction 51-57
Tubal Reconstructive Surgery
Gynecologic Surgery 609-630
Obstetrical complications in gestational carrier pregnancies. Fertility and Sterility
Fertil Steril. 2005 Mar;83(3):749-54
An unusual anatomical variation of a unicornuate uterus with a normal external uterine morphology
Fertility and Sterility 2004 Oct;82(4):950-3
Septate uterus with cervical duplication; a full term delivery after resection of a vaginal septum
Fertility and Sterility 2004 Apr;81(4):1125-6
Intensive luteal phase support after GnRH agonist trigger: it does help.
Reproductive biomedicine online 2012 Sep;25(3):329-30
GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Human reproduction (Oxford, England) 2005 Nov;20(11):3258-60; author reply 3260
Letrozole + GnRH Antagonist Protocol Early LH Rise and Cost-Effectiveness
GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis.
Reproductive biomedicine online 2016 Mar;32(3):274-85
Influence of embryo quality and number of previous cycles on pregnancy and multiple pregnancy rates in women aged 35 to 37 years who received two or three embryos.
Fertility and sterility 2005 Dec;84(6):1748-51
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
Fertility and sterility 2004 Oct;82(4):841-6
|Title or Abstract||Type||Sponsor/Event||Date/Year||Location|
|Dual Trigger with GnRH Agonist and hCG for the Treatment of “Immature Oocyte Syndrome”||Poster||American Society for Reproductive Medicine||2012||San Diego, California|
|Ovulatory Rate in Subsequent Clomiphene Citrate Cycle After “Stair-Step” CC Protocol||Poster||American Society for Reproductive Medicine||2012||San Diego, California|
|Potential Reasons why Patients do not Pursue Fertility Preservation After Referral for Consultation and Counseling||Talk||American Society for Reproductive Medicine||2012||San Diego, California|
|Maternal and Neonatal Outcomes After GnRH Agonist Trigger for Final Oocyte Maturation in Patients Undergoing IVF||Poster||American Society for Reproductive Medicine||2012||San Diego, California|
|Ooocyte Cryopreservation: A Prospective Pilot Study Comparing Fertilization and Embryo Development Between Fresh and Vitrified Sibling Oocytes||Talk||American Society for Reproductive Medicine||2011||Orlando, Florida|
|Routes of Estradiol Administration have no Effect on Pregnancy Rates in Frozen Embryo Transfer IVF Cycles||Poster||American Society for Reproductive Medicine||2011||Orlando, Florida|
|Dual Trigger of Oocyte Maturation with Leuprolide and Low Dose hCG to Optimize Pregnancy Rates in High Responders||Talk||American Society for Reproductive Medicine||2011||Orlando, Florida|
|Predictors of Clinical Pregnancy After Elective Single Embryo Transfer||Poster||American Society for Reproductive Medicine||2010||Denver, Colorado|
|Factors Predicting Successful Induction of Oocyte Maturation After GnRH Agonist Trigger||Poster||American Society for Reproductive Medicine||2010||Denver, Colorado|
|The Probability of Conception After GnRH Agonist Trigger in High Responders with Peak E2 levels < or = 4,000 pg/ml||Poster||American Society for Reproductive Medicine||2010||Denver, Colorado|
|Cleavage Stage Versus Blastocyst Stage Embryo Transfer in Frozen-Thawed Assisted Conception Cycles||Poster||American Society for Reproductive Medicine||2010||Denver, Colorado|
|Prevalence of Chronic Endometritis in Patients with Recurrent Implantation Failure Undergoing IVF-ET: Efficacy of Antibiotic and Anti-Inflammatory Treatment||Talk||ESHRE||2009||Amsterdam, Netherlands|
|Good-Prognosis Patients not Meeting Embryologic Criteria for a Single Blastocyst Transfer (SBT) Have Similar Pregnancy Rates but Higher Rate of Multiples than those Receiving a SBT||Poster||American Society for Reproductive Medicine||2009||Atlanta, Georgia|
|Decreasing IVF-Related Multiple Gestations: Impact of an Educational Intervention on Patients’ Desires to Transfer Multiple Embryos||Poster||American Society for Reproductive Medicine||2009||Atlanta, Georgia|
|Luteal Phase Estradiol (LP) Versus Luteal Phase Estradiol and Antagonist (LPG) Protocol for Controlled Ovarian Stimulation Prior to IVF in Poor Responders||Talk||American Society for Reproductive Medicine||2009||Atlanta, Georgia|
|Pregnancy Outcomes After GnRH-agonist Trigger in Patients Undergoing IVF with Gonadotropins and a GnRH-Antagonist||Poster||Society for Gynecologic Investigation||2008||San Diego, California|
|Low Risk of Multiple Pregnancies in ART for Women Over Age 40||Poster||American Society for Reproductive Medicine||2008||San Francisco, California|
|Case Report of Two Mother-Daughter Pairings for Gestational Carriers with Excellent Obstetrical Outcomes||Talk||American Society for Reproductive Medicine||2008||San Francisco, California|
|Follicular Flare Response Does not Predict IVF Success in Poor Responders Undergoing Controlled Ovarian Stimulation Using Microdose Leuprolide||Poster||American Society for Reproductive Medicine||2008||San Francisco, California|
|Letrozole Can be Used in Combination with GnRH Agonists in Poor Responders Without Negating its Beneficial Effects||Talk||American Society for Reproductive Medicine||2008||San Francisco, California|
|Outcomes of Premature LH Rise in Patients Undergoing IVF During a GnRH Antagonist Cycle||Poster||American Society for Reproductive Medicine||2008||San Francisco, California|
|Luteal Phase Ganirelix Protocol is as Effective as Microdose Leuprolide Protocol for Poor Responders Undergoing IVF; Preliminary Results from a Randomized Trial||Talk||American Society for Reproductive Medicine||2008||San Francisco, California|
|Leuprolide Acetate Trigger Effectively Prevents OHSS Without Compromising Clinical Outcomes in Patients with Serum Estradiol >4,000 pg/ml in IVF Cycles||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|Luteal Phase Circulating VEGF, Estradiol and Progesterone Levels After GnRH Agonist Trigger||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|GnRH Agonist Triggers: Do Subsequent Estradiol and Progesterone Levels Predict Pregnancy?||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|The In Vitro Viability, Steroidogenic, and VEGF Secretory Capacity of Human Luteinized Granulosa Cells After GnRH Agonist Trigger||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|Elective Cryopreservation of all Embryos After GnRH Agonist Trigger is not Justified Because of the Comparable Success Rates Between Fresh and Cryo-Thawed Embryo Transfers||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|Choice of Medication for Oocyte Maturation for IVF GnRH Antagonist Cycles: hCG vs Leuprolide Acetate||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|Elective Single Blastocyst Transfer in a Selected Group of Patients does not Adversely Affect the Probability of Conception and Reduces the Probability of Twin Gestation||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|Selection of First IVF Cycle Stimulation Protocol for Good Prognosis Patients: GnRH Antagonist vs. Agonist Protocols||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|The Role of Endometrial Function Test in Recurrent Implantation Failure in IVF||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|Reproductive Outcome of Women = 43 Years Old Undergoing ART Treatment with Their Own Oocytes||Poster||American Society for Reproductive Medicine||2007||Washington, DC|
|GnRH Agonist Trigger After GnRH Antagonist Co-Treatment for Prevention of OHSS in Patient with Polycystic Ovarian Syndrome||Talk||American Society for Reproductive Medicine||2006||New Orleans, Louisiana|
|The Use of GnRH Agonist to Induce Oocyte Maturation in High-Risk Patients Undergoing IVF Eliminates the Risk of Ovarian Hyperstimulation Syndrome – A Prospective Randomized Controlled Study||Talk||American Society for Reproductive Medicine||2006||New Orleans, Louisiana|
|Induction of Oocyte Maturation with GnRH Agonist in High Risk Patients Undergoing IVF Treatment does not Adversely Affect Implantation Rate||Talk||American Society for Reproductive Medicine||2006||New Orleans, Louisiana|
|Transfer of Two Versus Three Embryos in Women Less than 40 Years Old Undergoing Frozen Transfer Cycles||Poster||American Society for Reproductive Medicine||2006||New Orleans, Louisiana|
|Embryos not Meeting Criteria for Freezing at the Multicellular Stage can Result in Blastocysts with Implantation and Pregnancy Rates Comparable to Multicellular Embryos Which Meet Those Criteria||Poster||American Society for Reproductive Medicine||2006||New Orleans, Louisiana|
|Human Oocytes Express Gs G-Protein and the G-Protein-Coupled Receptor GPR3, Key Components in the Maintenance of Meiotic Arrest in Mouse||Poster||American Society for Reproductive Medicine||2006||New Orleans, Louisiana|
|Evaluation of Luteal Estradiol Patch and Gonadotropin-Releasing Hormone Antagonist Suppression Protocol (LPG) Before Gonadotropin Stimulation in Patients with a History of Multiple Failed Cycles||Poster||American Society for Reproductive Medicine||2006||New Orleans, Louisiana|
|Immunohystochemistry Confirms the Presence of Chronic Endometritis in Patients with Recurrent Implantation Failure||Poster||American Society for Reproductive Medicine||2006||New Orleans, Louisiana|
|Comparison of Luteal Estradiol Patch and Gonadotropin-Releasing Hormone Antagonist Suppression Protocol (LPG) Before Gonadotropin Stimulation versus Standard Microdose Lupron Protocol for Patients with a History of Poor IVF Outcomes||Talk||American Society for Reproductive Medicine||2006||New Orleans, Louisiana|
|Serum Estradiol Level on Day of Embryo Transfer is Associated with Implantation and Pregnancy Rates||Poster||American Society for Reproductive Medicine||2005||Montreal, Canada|
|Should In Vitro Fertilization Cycles be Canceled in Women 40 Years of Age and Older Who Produce Four or Less Oocytes?||Poster||American Society for Reproductive Medicine/Canadian Fertility and Andrology||2005||Montreal, Canada|
|The use of GnRH Agonist to Trigger Final Stages of Oocyte Maturation in Patients with PCOS and High Responders During IVF Treatment||Poster||Pacific Coast Reproductive Society||2005||Indian Wells, California|
|The Probability of Conception After Embryo Transfer Using Fresh or Cryo-Thawed Multicellular Embryos||Poster||Pacific Coast Reproductive Society||2005||Indian Wells, California|
|Prevention of OHSS with the use of GnRH Agonist to Trigger Final Oocyte Maturation After Cotreatment with GnRH Antagonist in Patients with PCOS or Previous High Response Undergoing IVF Treatment – A Prospective Randomized Clinical Trial||Talk||American Society for Reproductive Medicine and Canadian Fertility/Andrology||2005||Montreal, Canada|
|The Role of Endometrial Biopsy in the Evaluation of Recurrent Implantation Failure||Poster||American Society for Reproductive Medicine/Canadian Fertility and Andrology||2005||Montreal, Canada|
|Septate Uterus with Cervical Duplication; A full Term Delivery After Resection of a Vaginal Septum||Plenary Lecture||New England Fertility Society||2004||Bretton Woods, New Hampshire|
|Obstetrical and Perinatal Complications in Gestational Carrier Pregnancies||Poster||Pacific Coast Reproductive Society||2004||Rancho Mirage, California|
|The Outcome of IVF Treatment in Patients who Electively Inseminate < 4 oocytes||Poster||ASRM Annual Meeting||2004||Philadelphia, Pennsylvania|
|Predictive Value of Embryo Grading for Embryos with Known Outcomes||Poster||ASRM Annual Meeting||2004||Philadelphia, Pennsylvania|
|An Unusual Variation of a Unicornuate Uterus with a Normal External Uterine Morphology||Poster||World Congress on Controversies in Obstetrics, Gynecology and Infertility||2004||Las Vegas, Nevada|
|Septate Uterus||Talk||Danbury Hospital 19th Annual Joseph L. Belsky, M.D. Research Day||2004||Danbury, Connecticut|
|Transferring 2 or 3 Embryos in Women 35 to 37 Years Old: Influence of Embryo Quality and Number of Previous Cycles on Pregnancy and Multiple Pregnancy Rates||Poster||ASRM Annual Meeting||2003||San Antonio, Texas|
|Reducing the Dose of hCG in High Responders Does Not Affect the Outcomes of IVF||Talk||ASRM Annual Meeting||2002||Seattle, Washington|
|A Randomized, Prospective Study of Microdose Leuprolide vs. Ganirelix in IVF Cycles for Poor Responder Patients||Talk||ASRM Annual Meeting||2002||Seattle, Washington|
|Is Pronuclear Morphology Predictive of Outcome?||Poster||ASRM Annual Meeting||2002||Seattle, Washington|
|Microdose Leuprolide versus Ganirelix in “Poor Responder” Patients||Poster||American Society for Reproductive Medicine||2001||Orlando, Florida|
|Microdose GnRH Analog Flare Protocol Does Not Improve Outcome of IVF in Patients with Diminished Ovarian Reserve||Poster||American Society for Reproductive Medicine||1999||Toronto, Ontario, Canada|
|Intracytoplasmic Sperm Injection (ICSI) Overcomes Previous Fertilization Failure with Conventional In Vitro Fertilization (IVF)||Poster||American Society for Reproductive Medicine||1998||San Francisco, California|
|The Pharmacokinetics of the Sublingual Administration of Micronized Estradiol, Progesterone and Testosterone in Postmenopausal Women||Poster||American Society for Reproductive Medicine||1998||San Francisco, California|
|Effects of the Sublingual Administration of Micronized Estradiol, Progesterone and Testosterone on Bone Metabolism in Postmenopausal Women||Talk||ASBMR and IBMS||1998||San Francisco, California|
|The Effects of Sublingual Micronized Estradiol, Progesterone and Testosterone on Menopausal Symptoms and Sexual Health||Talk||ASBMR and IBMS||1998||San Francisco, California|
|The Effects of Sublingual Micronized Estradiol, Progesterone and Testosterone on Serum Lipids and Apolipoproteins||Talk||ASBMR and IBMS||1998||San Francisco, California|
|The Effects of Sublingual Micronized Estradiol, Progesterone and Testosterone on Pro-Coagulant and Anti-Coagulant Factors||Talk||ASBMR and IBMS||1998||San Francisco, California|
|Tubal Cannulation as a Treatment for Proximal Tubal Occlusion: Hysteroscopic Versus Fluoroscopic Approach||Poster||American Society for Reproductive Medicine||1997||Cincinnatti, Ohio|
|Implantation Efficiency in Women Over age 40 is Independent of the Magnitude of the Ovarian Response||Talk||Society for Gynecologic Investigation||1995||Chicago, Illinois|
|Sperm Morphology does not Correlate with Fertilization Rates in Normal Male Partners of Egg Donor Recipients||Poster||World Congress on In Vitro Fertilization and Assisted Reproduction||1995||Vienna, Austria|
|Progesterone Level on the day of hCG in Stimulated Cycles for IVF does not Influence Endometrial Thickness, Endometrial Pattern or IVF Outcome||Talk||World Congress on In Vitro Fertilization and Assisted Reproduction||1995||Vienna, Austria|
|Immunofluorescent Detection of Acrosin is More Reliable than Sperm Morphology in Predicting Fertilizing Ability In Vitro||Talk||World Congress on In Vitro Fertilization and Assisted Reproduction||1995||Vienna, Austria|
|Withholding Gonadotropin Administration is an Effective Alternative to Cryopreservation of All Embryos for the Prevention of Ovarian Hyperstimulation Syndrome||Poster||American Society for Reproductive Medicine||1995||Seattle, Washington|
|Chromosome 16 Aneuploidy Increases Significantly with Maternal Age in Preimplantation Human Embryos||Talk||American Society for Reproductive Medicine||1995||Seattle, Washington|
|Results of 12 Cases of Preimplantation Diagnosis of Aneuploidy in Women 40 Years or Older||Talk||American Society for Reproductive Medicine||1995||Seattle, Washington|
|Intracytoplasmic Sperm Injection (ICSI) is the Treatment of Choice for Immunological Infertility||Poster||American Society for Reproductive Medicine||1995||Seattle, Washington|
|Anticardiolipin Antibodies and Infertility||Talk||National Scientific Meeting of the American College of Rheumatology||1995||San Francisco, California|
|Clomiphene Citrate and Human Menopausal Gonadotropin: A Rescue Stimulation Protocol for Selected Failed In-Vitro Fertilization Patients||Poster||American Fertility Society||1994||San Antonio, Texas|
|Cumulative Probability of Pregnancy After In-Vitro Fertilization in Tubal Factor Infertility||Poster||American Fertility Society||1994||San Antonio, Texas|
|Uterine Factors Influence Implantation Rate in an Oocyte Donation Program||Talk||American Fertility Society||1994||San Antonio, Texas|
|Potential Role of Leukemia Inhibitory Factor (LIF) in the Differentiation of the Human Endometrium||Poster||American Society for Cell Biology||1994||San Francisco, California|
|Immunohistochemical Assessment of Estrogen and Progesterone Receptor Content in Endometrial Biopsies from Women with Endometrial Gland-Stroma Dyssynchrony Associated with hMG Superovulation||Talk||American Fertility Society and the Canadian Fertility and Andrology Society||1993||Montreal, Quebec, Canada|
|Laparoscopic Retropubic Urethral Suspension||Talk||European Society of Human Reproduction and Embryology||1993|
|Laparoscopic Management of Ovarian Benign Cystic Teratomas||Talk||World Congress of Gynecologic Endoscopy||1993||San Francisco, California|
|Superovulation with Human Menopausal Gonadotropins is Associated with Significant Endometrial Gland-Stroma Dyssynchrony||Poster||American Fertility Society||1992||New Orleans, Louisiana|
|Differences in Early Response to a GnRH Analog Influence the Outcome of In-Vitro Fertilization||Poster||Society for Gynecologic Investigation||1989||San Diego|
|Different Timing of hCG Administration After an Endogenous LH Surge Affects Fertilization and Outcomes of IVF||Poster||World Congress of IVF and Alternate Assisted Reproduction||1989||Jerusalem, Israel|
|Comparison of Different Regimens of a GnRH Agonist During Ovarian Stimulation for In-Vitro Fertilization||Talk||World Congress of IVF and Alternate Assisted Reproduction||1989||Jerusalem, Israel|
|Follicular Recruitment is Enhanced by the Additional Stimulatory Effect of a GnRH Analog During the Early Follicular Phase||Talk||American Fertility Society||1989||San Francisco, California|
|Ovarian Response to Human Menopausal Gonadotropin Following Suppression with Oral Contraceptives||Poster||The Society for Gynecologic Investigation||1988||Baltimore, Maryland|
|Ovarian Stimulation With an Increased Initial FSH/LH Ratio Does not Affect the Outcome of In-Vitro Fertilization||Poster||Society for Gynecologic Investigation||1988||Baltimore, Maryland|
|Bovine Serum Albumin can Replace Patient's Serum as a Protein Source in an In-Vitro Fertilization Program||Talk||American Fertility Society||1988||Atlanta, Georgia|
|Usefulness of Standard Semen Analysis in Predicting Fertilization in an IVF Program||Poster||American Fertility Society||1988||Atlanta, Georgia|
|Dose of Human Menopausal Gonadotropin Influences the Outcome of an In-Vitro Fertilization Program||Poster||World Congress on IVF-ET||1987||Norfolk, Virginia|
|Ovarian Response of Individuals to Different Doses of Human Menopausal Gonadotropin||Talk||American Fertility Society||1987||Reno, Nevada|
|Neoplasia of the Uterine Cervix in the Pregnant-Puerperal State||Talk||Argentine Society of Uterine-Cervical Pathology and Colposcopy||1984||Buenos Aires, Argentina|
|Tap-Test, A New Method to Evaluate the Fetal Pulmonary Maturity||Talk||Buenos Aires Society of Obstetrics and Gynecology||1984||Bahia Blanca, Argentina|
|Abortion at the Castex Hospital, period 1980/83||Talk||Buenos Aires Society of Obstetrics and Gynecology||1983||Buenos Aires, Argentina|
|Premature Labor in Low Socio-Economical Levels; Our Experience||Talk||Buenos Aires Society of Obstetrics and Gynecology||1982||Buenos Aires, Argentina|